182 related articles for article (PubMed ID: 17049756)
1. Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Drug Alcohol Depend; 2007 Apr; 88(1):36-41. PubMed ID: 17049756
[TBL] [Abstract][Full Text] [Related]
2. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periaqueductal grey of rats.
Chen X; Geller EB; Rogers TJ; Adler MW
Brain Res; 2007 Jun; 1153():52-7. PubMed ID: 17459345
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ blocks the antinociception induced by mu, kappa and delta opioid agonists on the cold water tail-flick test.
Chen X; Geller EB; Adler MW
Eur J Pharmacol; 2007 Feb; 557(1):32-6. PubMed ID: 17173891
[TBL] [Abstract][Full Text] [Related]
4. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
5. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
Riba P; Ben Y; Smith AP; Furst S; Lee NM
J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
[TBL] [Abstract][Full Text] [Related]
6. The effect of gp120 on morphine's antinociceptive and neurophysiological actions.
Chen X; Kirby LG; Palma J; Benamar K; Geller EB; Eisenstein TK; Adler MW
Brain Behav Immun; 2011 Oct; 25(7):1434-43. PubMed ID: 21569838
[TBL] [Abstract][Full Text] [Related]
7. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
Noble F; Cox BM
Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
[TBL] [Abstract][Full Text] [Related]
8. Analgesic efficacy of buprenorphine in the presence of high levels of SDF-1α/CXCL12 in the brain.
Benamar K; Palma J; Cowan A; Geller EB; Adler MW
Drug Alcohol Depend; 2011 Apr; 114(2-3):246-8. PubMed ID: 21112161
[TBL] [Abstract][Full Text] [Related]
9. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain.
Szabo I; Chen XH; Xin L; Adler MW; Howard OM; Oppenheim JJ; Rogers TJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10276-81. PubMed ID: 12130663
[TBL] [Abstract][Full Text] [Related]
10. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
Adams JU; Tallarida RJ; Geller EB; Adler MW
J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
[TBL] [Abstract][Full Text] [Related]
11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
12. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
13. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
14. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
Bilsky EJ; Qian X; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 2000 Apr; 293(1):151-8. PubMed ID: 10734164
[TBL] [Abstract][Full Text] [Related]
17. Activation of mu opioid receptors in the ventrolateral periaqueductal gray inhibits reflex micturition in anesthetized rats.
Matsumoto S; Levendusky MC; Longhurst PA; Levin RM; Millington WR
Neurosci Lett; 2004 Jun; 363(2):116-9. PubMed ID: 15172097
[TBL] [Abstract][Full Text] [Related]
18. Chronic sucrose intake augments antinociception induced by injections of mu but not kappa opioid receptor agonists into the periaqueductal gray matter in male and female rats.
Kanarek RB; Mandillo S; Wiatr C
Brain Res; 2001 Nov; 920(1-2):97-105. PubMed ID: 11716815
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
20. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]